Hear from George Church, Ph.D.
George Church, Ph.D., Professor of Genetics, Department of Genetics, Harvard Medical School
In advance of his keynote address at Boston CEO on May 28, Dr. George Church sits down with LeadingBiotech for a fascinating journey through topics including the future of gene editing and its ethical implications, the potential for Blockchain in reconciling patient privacy and data sharing, and the future of the Woolly Mammoth.
Hear from Laurie Glimcher, M.D.
Laurie Glimcher, M.D., President & CEO, Dana-Farber Cancer Institute
Laurie Glimcher is passionate about breakthroughs in cancer research, medical research funding, and the career progression of women. In advance of her fireside chat at Boston CEO on May 28, Laurie sits down with LeadingBiotech to discuss what drives her leadership at Dana-Farber.
Hear from Ed Kaye
Ed Kaye, CEO, Stoke Therapeutics
Ed Kaye, upcoming speaker at Boston CEO, sits down to talk with LeadingBiotech about his new job as CEO of Stoke Therapeutics, the importance of patient engagement and advocacy in therapeutic development, and advice for new CEOs based on his years of experience in the industry and the incredible relationships he has formed.
Hear from Andy Plump
Andy Plump, Chief Medical & Scientific Officer, Takeda
In this interview with LeadingBiotech, Andy Plump covers his personal journey as well as the journey of the company since he joined. He also discusses the new frontier in biotech and why Boston truly is the center of it all.
Hear from Paula Soteropolous
Paula Soteropolous, CEO, Akcea
Named one of Massachusetts’ Top 100 Women-Led Businesses, Paula Soteropoulos talks with LeadingBiotech about challenges of rapid company growth, her experiences as a CEO, and the value of gender parity in the boardroom and the workforce in advance of her upcoming participation at Boston CEO 2019.